Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuhn

Showing results (221-230 of 306) with videos related to

Pageof 31
Sort By:
BMJ Open|November 4, 2021
ROBOCOP II (ROBOtic assisted versus conventional open partial nephrectomy) randomised, controlled feasibility trial: clinical trial protocolKarl-Friedrich Kowalewski, Marie Angela Sidoti Abate, Manuel Neuberger, et al.
Journal of the American Chemical Society|October 3, 2018
Lymph-Node-Targeted Immune Activation by Engineered Block Copolymer Amphiphiles-TLR7/8 Agonist ConjugatesSimon Van Herck, Kim Deswarte, Lutz Nuhn, et al.
Biomacromolecules|December 13, 2019
Synthetic Rhamnose Glycopolymer Cell-Surface Receptor for Endogenous Antibody RecruitmentRuben De Coen, Lutz Nuhn, Chamani Perera, et al.
Urologic Oncology|June 17, 2021
High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancerKatja Nitschke, Thomas S Worst, Sophie Madeleine von Rhade, et al.
Stem Cell Research & Therapy|February 3, 2025
Exosomal mir-126-3p derived from endothelial cells induces ion channel dysfunction by targeting RGS3 signaling in cardiomyocytes: a novel mechanism in Takotsubo cardiomyopathyXuehui Fan, Guoqiang Yang, Yinuo Wang, et al.
Iscience|August 9, 2023
Reinvestigating the clinical relevance of the m<sup>6</sup>A writer METTL3 in urothelial carcinoma of the bladderJonas Koch, Manuel Neuberger, Martina Schmidt-Dengler, et al.
Urologic Oncology|April 15, 2026
Concordance and prognostic value of antibody drug conjugate and checkpoint inhibition targets in matched bladder cancer specimens from transurethral resection of the bladder, radical cystectomy and lymphadenectomyDaniel Uysal, Bruno Reible, Lukas Wildner, et al.
Biomacromolecules|May 28, 2016
pH-Degradable Mannosylated Nanogels for Dendritic Cell TargetingRuben De Coen, Nane Vanparijs, Martijn D P Risseeuw, et al.
Advances in Therapy|October 10, 2020
Adherence to the EAU Guideline Recommendations for Local Tumor Treatment in Penile Cancer: Results of the European PROspective Penile Cancer Study Group Survey (E-PROPS)Maximilian Pallauf, Marie C Hempel, Marie C Hupe, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
The Emerging Role of Multimodal Artificial Intelligence in Urological SurgeryLeonhard Buck, Jakob Kohler, Julian Risch, et al.
Pageof 31

Showing results (221-230 of 306) with videos related to

Sort By:
Pageof 31
BMJ Open|November 4, 2021
ROBOCOP II (ROBOtic assisted versus conventional open partial nephrectomy) randomised, controlled feasibility trial: clinical trial protocolKarl-Friedrich Kowalewski, Marie Angela Sidoti Abate, Manuel Neuberger, et al.
Journal of the American Chemical Society|October 3, 2018
Lymph-Node-Targeted Immune Activation by Engineered Block Copolymer Amphiphiles-TLR7/8 Agonist ConjugatesSimon Van Herck, Kim Deswarte, Lutz Nuhn, et al.
Biomacromolecules|December 13, 2019
Synthetic Rhamnose Glycopolymer Cell-Surface Receptor for Endogenous Antibody RecruitmentRuben De Coen, Lutz Nuhn, Chamani Perera, et al.
Urologic Oncology|June 17, 2021
High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancerKatja Nitschke, Thomas S Worst, Sophie Madeleine von Rhade, et al.
Stem Cell Research & Therapy|February 3, 2025
Exosomal mir-126-3p derived from endothelial cells induces ion channel dysfunction by targeting RGS3 signaling in cardiomyocytes: a novel mechanism in Takotsubo cardiomyopathyXuehui Fan, Guoqiang Yang, Yinuo Wang, et al.
Iscience|August 9, 2023
Reinvestigating the clinical relevance of the m<sup>6</sup>A writer METTL3 in urothelial carcinoma of the bladderJonas Koch, Manuel Neuberger, Martina Schmidt-Dengler, et al.
Urologic Oncology|April 15, 2026
Concordance and prognostic value of antibody drug conjugate and checkpoint inhibition targets in matched bladder cancer specimens from transurethral resection of the bladder, radical cystectomy and lymphadenectomyDaniel Uysal, Bruno Reible, Lukas Wildner, et al.
Biomacromolecules|May 28, 2016
pH-Degradable Mannosylated Nanogels for Dendritic Cell TargetingRuben De Coen, Nane Vanparijs, Martijn D P Risseeuw, et al.
Advances in Therapy|October 10, 2020
Adherence to the EAU Guideline Recommendations for Local Tumor Treatment in Penile Cancer: Results of the European PROspective Penile Cancer Study Group Survey (E-PROPS)Maximilian Pallauf, Marie C Hempel, Marie C Hupe, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
The Emerging Role of Multimodal Artificial Intelligence in Urological SurgeryLeonhard Buck, Jakob Kohler, Julian Risch, et al.
Pageof 31